We identified androgen-dependent TROP2high cells as a population of cells that drives post-treatment re-growth, while high membrane TROP2 expression represents a hallmark of self-renewing TICs in aggressive androgen-independent tumor cells. This evidence concerns the gene TACSTD2 and neoplasm.